Key result
Dilute Russell viper venom time (dRVVT) demonstrated 100% sensitivity for detecting clinically relevant rivaroxaban plasma concentrations, while prothrombin time (PT) and activated partial thromboplastin time (aPTT) showed higher specificity.
Why the study?
Do PT, aPTT, and dRVVT accurately evaluate the hemorrhagic risk by estimating plasma concentration in patients taking rivaroxaban compared to anti-FXa assay?
Observational (n=100)
No
Do PT, aPTT, and dRVVT accurately evaluate the hemorrhagic risk by estimating plasma concentration in patients taking rivaroxaban compared to anti-FXa assay?
dRVVT is a highly sensitive screening test for detecting clinically relevant rivaroxaban plasma concentrations, but requires a second test like anti-FXa or PT to improve specificity.
Answers are grounded in this paper and cite their sources.
dRVVT may aid sensitive rivaroxaban detection in select settings; leaves open prospective outcome validation versus PT/aPTT.
BACKGROUND: Rivaroxaban is a direct oral anticoagulant designed to dispense with the necessity of laboratory monitoring. However, monitoring rivaroxaban levels is necessary in certain clinical conditions, especially in the critical care setting. METHODS: This is a diagnostic accuracy study evaluating sensitivity and specificity of prothrombin time (PT), activated partial thromboplastin time (aPTT), and Dilute Russell viper venom time (dRVVT), to evaluate the hemorrhagic risk in patients taking rivaroxaban. The study used a convenience sample of 40 clinically stable patients using rivaroxaban to treat deep vein thrombosis or atrial fibrillation admitted in a private hospital in Brazil, compared to a group of 60 healthy controls. The samples from patients were collected two hours after the use of the medication (peak) and two hours before the next dose (trough). RESULTS: The correlation with the plasmatic concentration measured by anti-FXa assay was higher for PT and dRVVTS. The PT and aPTT tests presented higher specificity, while dRVVT was 100% sensible. CONCLUSIONS: There was a strong correlation between the tests and the plasma concentration of the drug. Additionally, our results demonstrated the potential use of dRVVT as a screening test in the emergency room and the need of a second test to improve specificity.
No takes yet. Share an insight, caveat, or question.
Colombini et al. (2017) conducted an observational in Deep vein thrombosis or atrial fibrillation (n=100). Coagulation tests (PT, aPTT, dRVVT) vs. Anti-FXa assay (reference standard) was evaluated on Sensitivity and specificity of PT, aPTT, and dRVVT for detecting clinically relevant rivaroxaban plasma concentrations. Dilute Russell viper venom time (dRVVT) demonstrated 100% sensitivity for detecting clinically relevant rivaroxaban plasma concentrations, while prothrombin time (PT) and activated partial thromboplastin time (aPTT) showed higher specificity.
Synapse has enriched 10 related papers. Consider them for comparative context: